UNICA IRIS Institutional Research Information System

MACCIONI, ELIAS
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 306.389
NA - Nord America 11.855
AS - Asia 5.373
SA - Sud America 762
AF - Africa 195
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
Totale 324.588
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 302.820
US - Stati Uniti d'America 11.674
SG - Singapore 2.082
CN - Cina 1.998
UA - Ucraina 950
SE - Svezia 818
BR - Brasile 588
DE - Germania 476
VN - Vietnam 437
FI - Finlandia 428
GB - Regno Unito 280
FR - Francia 261
IN - India 167
HK - Hong Kong 153
CA - Canada 102
KR - Corea 100
MA - Marocco 77
BD - Bangladesh 76
NL - Olanda 61
AR - Argentina 60
PK - Pakistan 52
IQ - Iraq 50
RU - Federazione Russa 50
MX - Messico 47
AT - Austria 46
TR - Turchia 38
JP - Giappone 37
PL - Polonia 36
ZA - Sudafrica 36
IE - Irlanda 28
EC - Ecuador 27
ID - Indonesia 27
SA - Arabia Saudita 27
ES - Italia 26
CO - Colombia 24
BE - Belgio 23
VE - Venezuela 23
KE - Kenya 19
PH - Filippine 19
TN - Tunisia 17
EG - Egitto 15
IR - Iran 14
CZ - Repubblica Ceca 13
LT - Lituania 13
CL - Cile 12
UZ - Uzbekistan 12
PY - Paraguay 11
JO - Giordania 10
NP - Nepal 10
RO - Romania 10
AE - Emirati Arabi Uniti 9
CR - Costa Rica 9
IL - Israele 9
PT - Portogallo 9
ET - Etiopia 8
PA - Panama 8
PE - Perù 8
EU - Europa 7
HU - Ungheria 7
AL - Albania 6
BO - Bolivia 6
MY - Malesia 6
KG - Kirghizistan 5
MD - Moldavia 5
MU - Mauritius 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
KW - Kuwait 4
KZ - Kazakistan 4
LB - Libano 4
CH - Svizzera 3
GE - Georgia 3
JM - Giamaica 3
NG - Nigeria 3
NI - Nicaragua 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
HR - Croazia 2
IS - Islanda 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
A1 - Anonimo 1
AM - Armenia 1
AW - Aruba 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
Totale 324.568
Salva come PNG Salva come JPEG
Città #
Cagliari 296.857
Uta 5.289
Singapore 1.086
Ashburn 992
Fairfield 990
Chandler 875
Woodbridge 848
Dallas 656
Houston 645
Ann Arbor 531
Nyköping 529
San Jose 506
Boardman 496
Jacksonville 493
Wilmington 411
Seattle 403
Beijing 398
Dearborn 378
Cambridge 303
Helsinki 277
Los Angeles 216
New York 200
Nanjing 171
Santa Clara 169
The Dalles 168
Lauterbourg 152
Shanghai 147
Boston 138
Ho Chi Minh City 136
Hong Kong 134
Hefei 133
Council Bluffs 101
Seoul 97
Hanoi 93
Buffalo 76
Casablanca 64
Redwood City 64
Shenyang 61
Guangzhou 55
Nanchang 54
Dong Ket 53
Munich 52
San Diego 52
São Paulo 52
Toronto 49
Amsterdam 47
Milan 46
Orem 44
Jiaxing 42
Changsha 41
Hebei 41
Verona 41
Frankfurt am Main 39
Sassari 38
Chennai 34
Jinan 34
Tianjin 34
Warsaw 34
London 31
Vienna 30
Montreal 29
Mountain View 29
Chicago 28
Kunming 28
Redondo Beach 28
Tokyo 28
Phoenix 27
Herndon 24
Norwalk 24
Dublin 23
Johannesburg 22
Atlanta 21
Brussels 21
Mumbai 20
Zhengzhou 20
Brooklyn 19
Washington 19
Auburn Hills 18
Hangzhou 18
Nuremberg 18
Pune 18
Nairobi 17
Orange 17
Taizhou 17
Baghdad 16
Rome 16
San Francisco 16
Manchester 15
Ningbo 15
Rio de Janeiro 15
Wuhan 15
Da Nang 14
Lahore 14
Columbus 13
Haiphong 13
Denver 12
Dhaka 12
Mexico City 12
Stockholm 12
Tashkent 12
Totale 316.981
Salva come PNG Salva come JPEG
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.717
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.056
Methoxyflavones from Stachys glutinosa with binding affinity to opioid receptors: in silico, in vitro, and in vivo studies 4.697
Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders 4.687
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.678
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.518
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.460
Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors 4.436
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.404
Lactoferrin- and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: Preparation and in vivo evaluation 4.366
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.322
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: A new scaffold for the selective inhibition of monoamine oxidase B 4.316
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.179
N-Alkyl dien- and trienamides from the roots of Otanthus maritimus with binding affinity for opioid and cannabinoid receptors 3.939
New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII 3.928
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold 3.776
A novel series of 3,4-disubstituted dihydropyrazoles: Synthesis and evaluation for MAO enzyme inhibition 3.772
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.744
Ferulic Acid Esters and Withanolides: in Search of Withania somnifera GABAA Receptor Modulators 3.607
Targeting tumor associated carbonic anhydrase IX and XII: Highly isozyme selective coumarin and psoralen inhibitors 3.538
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.477
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.426
Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation 3.421
N-alkylamides from Otanthus maritimus: structure elucidation, binding affinity for cannabinoid receptors and computational study 3.412
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.365
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.303
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.302
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.292
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B 3.278
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase 3.214
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.194
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 3.099
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 3.081
Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids 3.036
Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides 3.031
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.031
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) enlighten the mechanism of action of a new Ribonuclease H/DNA polymerase RT dual inhibitor 2.963
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.913
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.901
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.856
MD protocol validation for the study of MAOB-inhibitor complexes 2.771
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.766
In search of new antitumor agents through the combination of individually active moieties: construction of a [3,5-diaryl-(4,5- dihydropyrazol-1-yl)-4-oxo-1,3-thiazol-5-ylidene]- 1H-indol-2-ones library 2.742
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.728
Structure-based virtual screening of novel natural alkaloid derivatives as potential binders of h-telo and c-myc DNA G-quadruplex conformations 2.633
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.626
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.606
Towards the total block of HIV-1 Reverse Transcriptase: the dual-inhibitors approach 2.603
Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases 2.547
Investigation on the mechanism of action of new dual inhibitors of HIV-1 RT 2.541
Synthesis and characterization of new phthalhydrazothiazole derivatives: A preliminary investigation on their activity against hepatocellular carcinoma 2.525
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.450
New dual inhibitors of RT associated functions: investigation on their mechanism and mode of action 2.441
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.429
New promising scaffolds for the inhibition of monoamine oxidase B 2.300
Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement 2.292
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.255
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.179
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.131
Meeting report: Third Summer School on innovative approaches for identification of antiviral agents (IAAASS) 2.104
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 2.103
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 2.074
Design, synthesis and biological activity evaluation of c-myc proto-oncogene binders as potential antitumor agents 2.070
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.068
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.962
null 1.949
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.926
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.920
New reactions of carbon suboxide with alkines 1.916
Semipreparative HPLC enantioseparation, chiroptical properties, and absolute configuration of two novel cyclooxygenase-2 inhibitors 1.893
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.876
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors 1.862
Brain delivery of the NK3 receptor agonist senktide by immunoliposome: an in vivo microdialysis study 1.820
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.805
SITE DIRECT MUTAGENESIS AND KINETIC STUDIES TO EXPLORE THE MECHANISM OF ACTION OF ISATIN DERIVATIVES AS HIV-1 REVERSE TRANSCRIPTASE DUAL INHIBITORS 1.790
Application of an immobilised amylose-based chiral stationary phase to the development of new monoamine oxidase B inhibitors 1.781
New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII 1.733
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.699
SYNTHESIS, MOLECULAR MODELLING, INHIBITORY ACTIVITY, AND SELECTIVITY TOWARDS MONOAMINE OXIDASE OF NEW HETEROCYCLIC SCAFFOLDS 1.678
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.662
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.651
Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey 1.635
Flavonoids and Acid-Hydrolysis derivatives of Neo-Clerodane diterpenes from Teucrium flavum subsp. glaucum as inhibitors of the HIV-1 reverse transcriptase–associated RNase H function 1.627
Synthesis and biological evaluation of new dual inhibitors of HIV-1 associated functions 1.607
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.594
From classic to innovative approaches in HIV-1 infection treatment 1.550
null 1.499
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.467
Shape based computer aided similarity screening: a valid tool in the discovery of new scaffolds for the inhibition of HIV-1 reverse transcriptase associated ribonuclease H function 1.421
null 1.415
null 1.406
Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization 1.330
The preparation of non ionic surfactant vesicles formed from hexacyclophosphazenic derivatives 1.282
9-fluorenones as new scaffolds for G-quadruplex DNA 1.234
Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions 1.190
Synthesis of new arylidencycloalkylpyrazoles of potential biological interest 1.186
A combined shape-, 2D-fingerprint-and pharmacophore-based virtual screening for the identification of dual inhibitors targeting HIV-1 reverse transcriptase. 1.172
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.126
Design, synthesis and biological evaluation of new fluorenone derivatives as DNA G-quadruplex binders 1.122
Synthesis, molecular modelling, inhibitory acivity, and selectivity towards monoamine oxidase of new heterocyclic scaffold 1.106
Totale 273.611
Salva come PNG Salva come JPEG
Categoria #
all - tutte 383.675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 383.675
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111.224 0 0 0 0 0 0 0 0 0 4.479 4.401 2.344
2021/202214.008 1.700 1.214 707 981 1.186 930 870 734 1.327 1.365 1.419 1.575
2022/202323.332 2.103 3.454 2.892 2.226 1.572 2.521 1.290 1.647 1.248 1.333 1.869 1.177
2023/202422.577 1.096 695 2.080 1.828 2.344 3.929 2.885 1.628 1.203 1.336 1.657 1.896
2024/202549.847 15.268 14.318 6.700 4.383 2.091 2.671 2.480 205 516 346 344 525
2025/202610.492 802 459 1.439 1.138 908 750 1.750 1.146 947 1.153 0 0
Totale 325.120